| Bioactivity | FKBP51F67V-selective antagonist Ligand2 (example 3-3) is a potent FKBP51 F67V-selective antagonist ligand. FKBP51F67V-selective antagonist Ligand2 reverses the anxiogenic phenotype induced by overexpression of FKBP51 F67V in the amygdala. FKBP51F67V-selective antagonist Ligand2 binds to FKBP51 F67V, but not to wild-type FKBP51 or FKBP52[1]. |
| Name | FKBP51F67V-selective antagonist Ligand2 |
| CAS | 1680228-76-5 |
| Formula | C43H56N2O10 |
| Molar Mass | 760.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Steffen GAALI, et al. Selective fkbp51 ligands for treatment of psychiatric disorders. Patent, WO2015039758A1. |
FKBP51F67V-selective antagonist Ligand2
CAS: 1680228-76-5 F: C43H56N2O10 W: 760.91
FKBP51F67V-selective antagonist Ligand2 (example 3-3) is a potent FKBP51 F67V-selective antagonist ligand. FKBP51F67V-se
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.